MannKind Corp Files Definitive Proxy Statement

TL;DR

<b>MannKind Corporation has filed its Definitive Proxy Statement for the 2024 Stockholder Meeting, detailing executive compensation and stock award information.</b>

AI Summary

MANNKIND CORP (MNKD) filed a Proxy Statement (DEF 14A) with the SEC on April 5, 2024. MannKind Corporation filed a Definitive Proxy Statement on April 5, 2024. The filing is for the 2024 Meeting of Stockholders. The company's fiscal year ends on December 31st. The filing includes information related to stock awards and equity awards for the fiscal year 2023. MannKind Corporation is incorporated in Delaware and headquartered in Danbury, CT.

Why It Matters

For investors and stakeholders tracking MANNKIND CORP, this filing contains several important signals. This filing provides crucial details about executive compensation, stock awards, and other governance matters that directly impact shareholder decisions and company oversight. As a DEF 14A filing, it is a formal communication to shareholders regarding the annual meeting, including proposals to be voted on and information about the company's leadership and financial performance.

Risk Assessment

Risk Level: low — MANNKIND CORP shows low risk based on this filing. The filing is a routine proxy statement, indicating standard corporate governance procedures rather than immediate financial or operational shifts.

Analyst Insight

Review the executive compensation and stock award details to understand potential impacts on shareholder value and company strategy.

Key Numbers

• 2024 — Meeting Year (2024 Meeting of Stockholders)
• 2023-12-31 — Fiscal Year End (Fiscal Year End)
• 2023-01-01 — Reporting Period Start (Reporting period for stock awards)
• 2023-12-31 — Reporting Period End (Reporting period for stock awards)

Key Players & Entities

• MANNKIND CORP (company) — Registrant
• 0000950170-24-042052 (document_id) — Accession Number
• 2024-04-05T00:00:00.000Z (date) — Filed as of date
• 2024-05-15 (date) — Conformed period of report
• 0000899460 (company_id) — Central Index Key
• 2834 (industry_code) — Standard Industrial Classification
• DE (state) — State of Incorporation
• 1 Casper Street, Danbury, Connecticut 06810 (address) — Business Address

FAQ

Industry Context

MannKind Corporation operates in the Pharmaceutical Preparations industry, focusing on the development and commercialization of therapeutic products.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.

What Investors Should Do

1. Analyze the proposals presented in the proxy statement for the 2024 Annual Meeting.
2. Review the executive compensation details, including stock awards and option grants.
3. Understand the company's governance structure and any proposed changes.

Key Dates

• 2024-04-05: Filing Date — Definitive Proxy Statement filed
• 2024-05-15: Meeting Date — Conformed period of report for the meeting

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard annual proxy statement, indicating routine corporate governance activities.

Filing Documents

• mnkd-20240405.htm (DEF 14A) — 1624KB
• img30985660_0.jpg (GRAPHIC) — 591KB
• img30985660_1.jpg (GRAPHIC) — 27KB
• img30985660_2.jpg (GRAPHIC) — 27KB
• img30985660_3.jpg (GRAPHIC) — 5KB
• img30985660_4.jpg (GRAPHIC) — 6KB
• img30985660_5.jpg (GRAPHIC) — 7KB
• img30985660_6.jpg (GRAPHIC) — 31KB
• img30985660_7.jpg (GRAPHIC) — 27KB
• img30985660_8.jpg (GRAPHIC) — 28KB
• img30985660_9.jpg (GRAPHIC) — 5KB
• img30985660_10.jpg (GRAPHIC) — 123KB
• img30985660_11.jpg (GRAPHIC) — 112KB
• 0000950170-24-042052.txt (&nbsp;) — 5098KB
• mnkd-20240405.xsd (EX-101.SCH) — 81KB
• mnkd-20240405_htm.xml (XML) — 224KB

Executive Compensation – Compensation Discussion and Analysis

Executive Compensation – Compensation Discussion and Analysis 27 Compensation Committee Report 50

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 51 Householding of Proxy Materials, Annual Report and Other Matters 53 Proxy S tatement MANNKIND CORPORATION 1 Casper Street Danbury, Connecticut 06810 (818) 661-5000 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS To be held on May 15, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why did I receive a notice regarding the availability of proxy materials on the Internet? Pursuant to rules adopted by the Securities and Exchange Commission (the "SEC"), we have elected to provide access to our proxy materials over the Internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the "Notice") because the Board of Directors (sometimes referred to as the "Board") of MannKind Corporation (sometimes referred to as "we," "us," the "Company" or "MannKind") is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders (the "Annual Meeting"), including any adjournments or postponements of the Annual Meeting. This year's Annual Meeting will be held entirely via the Internet. You are invited to attend the Annual Meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the meeting via the Internet to vote your shares. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the Internet or to request a printed copy may be found in the Notice. The Notice will be mailed on April 5, 2024 to our stockholders of record entitled to vote at the Annual Meeting. Will I receive any other proxy materials by mail? We may send you a proxy card, along with a second Notice, ten days after mailing the first Notice. Why are we holding a virtual Annual Meeting? In recent years we have implemented a virtual format

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS These proxy materials contain "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on our current expectations and involve risks and uncertainties. No forward-looking statement can be guaranteed and actual results may differ materially from those stated or implied by forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, except as required under applicable law. Forward-looking statements should be evaluated together with the many risks and uncertainties that affect our business, particularly those mentioned under the "Risk Factors" heading of our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on February 27, 2024. 6 Prop osal 1 ELECTION OF DIRECTORS Our Board currently consists of nine directors. There are nine nominees for director this year, all of whom were nominated by our Board, consisting of our incumbent directors. Each director to be elected will hold office until the next annual meeting of stockholders and until his or her successor is elected, or until the director's earlier death, resignation or removal. All nominees listed below are currently our directors and were previously elected by our stockholders at the 2023 Annual Meeting of Stockholders. It is our policy that directors are invited and expected to attend annual meetings. All of our directors attended the 2023 Annual Meeting of Stockholders. Directors are elected by a plurality of the votes properly cast at the Annual Meeting or by proxy. The nine nominees receiving the highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the nine nominees named below. If any nominee becomes unavailable for election as a result of an unexpected occurrence, your shares may be voted for th

View Full Filing

View this DEF 14A filing on SEC EDGAR